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Summary
Acute aortic dissection is a rare but life-threatening con-
dition with a lethality rate of 1 to 2% per hour after onset
of symptoms in untreated patients. Therefore, its prompt
and proper diagnosis is vital to increase a patient’s chance
of survival and to prevent grievous complications. Typical
symptoms of acute aortic dissection include severe chest
pain, hypotension or syncope and, hence, mimic acute
myocardial infarction or pulmonary embolism. Advanced
age, male gender, long-term history of arterial hyperten-
sion and the presence of aortic aneurysm confer the great-
est population attributable risk. However, patients with ge-
netic connective tissue disorders such as Marfan, Loeys
Dietz or Ehlers Danlos syndrome, and patients with bicus-
pid aortic valves are at the increased risk of aortic dis-
section at a much younger age. Imaging provides a ro-
bust foundation for diagnosing acute aortic dissection, as
well as for monitoring of patients at increased risk of aor-
tic disease. As yet, easily accessible blood tests play only
a small role but have the potential to make diagnosis and
monitoring of patients simpler and more cost-effective.
Key words: acute aortic syndrome, aortic aneurysm, con-
nective tissue disorder, biomarkers, echocardiography,
computer tomography
Introduction
Acute aortic syndrome refers to a group of interrelated life-
threatening conditions and consists of aortic dissection, in-
tramural haematoma and penetrating atherosclerotic ulcer.
The incidence of acute aortic syndromes in the general
population ranges from 4 to 6 cases per 100 000 person-
years, but increases up to 30 or more in people older than
65 years [1–3].
The classification of the aortic dissection is based on both
anatomical location of the initial tear and the time from
the onset of the symptoms to the presentation at the emer-
gency department. According to the more popular Stanford
system, dissections involving the ascending aorta are clas-
sified as type A, whereas those involving only the de-
scending aorta are classified as type B. The older DeBakey
system differentiates between dissections evolving from
the ascending aorta and affecting all aortic segments (type
I), less extensive ones affecting only the ascending frag-
ment (type II), and dissections affecting only descending
aorta (type III) (fig. 1). With respect to the time from the
onset of the symptoms, aortic dissections are divided into
acute (presentation within 1 week), subacute (from 1 week
to 1 month) and chronic (more than 1 month).
Possible complications of aortic dissection include lethal
malperfusion syndrome, aortic regurgitation, cardiac fail-
ure (myocardial infarction or cardiac tamponade) and
stroke [4].
Even in elderly patients with other comorbidities, surgical
repair is the method of choice for the patients presenting
with acute type A aortic dissection. Patients with type B
dissection are usually treated medically, unless life-threat-
ing complications, such as malperfusion syndrome, occur.
The main aim of medical therapy is to reduce shear stress
on the diseased aortic segment by reducing blood pressure
and heart rate, as well as to relieve pain [5].
As a result of the devastating complications, the mortality
rate of aortic dissection remains high. In patients with
acute type A aortic dissection, the most severe form, the
mortality rate amounted to 26% if they received surgery,
but up to 58% if they could only be treated noninvasively
because of advanced age or the presence of comorbidities
Figure 1: Classification of aortic dissection according to Stanford
and DeBakey (drawn by J. Gawinecka).
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[4]. However, owing to the surgical advances and im-
proved postoperative management, the mortality dropped
during the last decade to 12% [6]. The early survival of pa-
tients presenting with acute type A aortic dissection is af-
fected by preoperative conditions such as previous aortic
valve replacement, migrating chest pain, preoperative limb
ischaemia, hypotension during presentation, or shock / car-
diac tamponade [7]. In turn, long-term survival is influ-
enced by preoperative renal impairment, reduced left ven-
tricular ejection fraction and advanced age [8]. Patients
with type B dissection managed medically have the lowest
mortality rate of 11%, which can, however, increase up to
31% when patients have to undergo surgery because of the
complications [4].
Pathogenesis
Aortic dissection arises from a tear in the aortic intima ex-
posing the medial layer to the pulsatile blood flow. The in-
timal tear is frequently found in segments exposed to the
greatest shear stress, namely the right lateral wall (oppo-
site the main pulmonary artery) of the ascending aorta or
in the proximal segment of the descending aorta. The pro-
gressive separation of the aortic wall layers results in the
formation of a false lumen and its subsequent propagation
can be followed either by aortic rupture in the case of ad-
ventitial disruption, or by re-entry back into the true lumen
through another intimal tear. Aortic rupture quickly leads
to exsanguination and death. In the event of blood redirec-
tion into the true lumen, creating natural fenestration, the
patient can present as relatively stable with adequate perfu-
sion. The false lumen may also end blindly in a cul-de-sac,
creating a blood clot. Rarely, when thrombosis occurs very
early in the event, the thrombosed false lumen is smaller
than the true lumen. When thrombosis occurs late, the false
lumen is usually larger than the true one. Moreover, the
false lumen grows during blood clotting and further com-
presses the true lumen, leading to decreased systemic per-
fusion. The dissection can also extend into aortic branches
and increase mortality risk, especially if coronary arteries
are involved [9, 10].
An electron microscopy study showed that the extracellu-
lar matrix is spare in the interlamellar space of the medial
layer at the dissection entry site and adjacent intact tissue,
and spirally thickened collagen fibrils are often accompa-
nied by attenuated, fragmented or disrupted elastic lamel-
lae. Moreover, the basement membrane of the smooth mus-
cle cells is usually thin or even lacking. In contrast, the
intimal layer does not show any specific changes in the
aortic dissection [11].
At the molecular level, aortic dissection is the result of
remodelling of the aortic wall structure as a result of in-
flammation and extracellular matrix degradation. Activat-
ed macrophages infiltrate the tunica media and release
matrix metalloproteinases (MMPs) and pro-inflammatory
cytokines. The excessive production of MMP-1, MMP-9
and MMP-12 leads to the accelerated degradation of colla-
gen and elastin fibres [12]. These MMPs also play a role in
the pathogenesis of aortic aneurysm and Marfan syndrome
[13–15]. Not only the increased release of MMPs them-
selves, but also the imbalance between them and their tis-
sue inhibitors (TIMPs) promote the proteolytic dominance
in aortic dissection [14, 16].
VEGF-mediated neoangiogenesis may be another process
underlying aortic wall remodelling. VEGF (vascular en-
dothelial growth factor) is the growth factor driving angio-
genesis and vasculogenesis, but it also exerts proinflam-
matory actions. The production of VEGF is increased in
the neovessels and their surrounding immune-inflammato-
ry infiltrate of the degraded medial layer [12].
Arterial hypertension is, as described below, one of the
main risk factors for aortic dissection. It can act directly
as a parietal stressor and indirectly as a proinflammatory
trigger, mainly by inducing macrophage recruitment and
activation [17]. The hypertensive patients show elevated
concentrations of proinflammatory molecules such as in-
terleukin (IL)-6, VEGF, macrophage chemoattractant pro-
tein-1 (MCP-1), MMP-2 and MMP-9 [18–21], suggesting
that hypertension promotes a proinflammatory state, which
subsequently leads to the excessive extracellular matrix de-
generation and culminates in the aortic dissection.
Risk factors
So far several risk factors for developing aortic dissection
are recognised (table 1).
With an age-adjusted incidence of five versus two per
100 000 person-years, men are at higher risk of developing
aortic dissection than women [1]. The sex distribution is
consistent in both type A and type B dissection. Usually,
women affected by aortic dissection are older and present
more frequently with congestive heart failure, coma or al-
tered mental status at hospital admission than men. Women
with type A dissection also have a higher in-hospital mor-
tality rate. This may be due to the older age, delayed pre-
sentation at the hospital or delayed diagnosis because of
the less typical symptoms [22].
The incidence of aortic dissection correlates with age. The
mean age at the onset of aortic dissection is approximately
65 years. Usually, patients with type A dissection are
younger than those with type B dissection [1, 4]. In pa-
tients with connective tissue diseases or a bicuspid aortic
valve, aortic dissection frequently occurs before 40 years
of age [22]. The elderly patients suffer more frequently
from other comorbidities such as hypertension, diabetes
mellitus or atherosclerosis, and more often have a history
of cardiac surgery or aortic aneurysm. Compared with the
younger patients, they less often experience an abrupt on-
set of pain and pulse deficits [23].
Table 1: Risk factors for aortic dissection.
Male sex
Age >65 years
Hypertension
Smoking
Aneurysm
Congenital disorders
Marfan syndrome
Loeys-Dietz syndrome
Vascular Ehlers-Danlos syndrome
Bicuspid aortic valve
Inflammatory disease
Aortitis
Giant cell arteritis
Takayasu arteritis
Systemic lupus erythematous
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Hypertension is considered as the most important risk fac-
tor for aortic dissection and is present in about 80% of pa-
tients with aortic dissection. In the general population, hy-
pertension contributes 54% of population-attributable risk
of acute aortic dissection, and with an incidence rate of 21
per 100 000 person-years compared with 5 in normoten-
sive individuals [4, 24]. Patients with higher blood pres-
sure during the 5 years before the occurrence of the aortic
dissection die more often before reaching hospital than
those with lower blood pressure or better hypertension
control [2].
Smoking is another risk factor for developing aneurysm
and aortic dissection. Compared with nonsmokers, smok-
ers suffer from aortic dissection and thoracic aortic
aneurysm twice as frequently and from abdominal aortic
aneurysm even five times more frequently [2].
The annual rate of acute aortic dissection progressively in-
creases as the aortic diameter increases, and the incidence
of aortic complications reaches 30% once the aortic diam-
eter reaches 60 mm [25]. Although aortic dilatation clearly
increases the risk of aortic dissection, dilatation is not es-
sential for dissection, and approximately 60% of acute type
A aortic dissections occur at aortic diameters <55 mm [26].
Aortitis, complications caused by giant cell arteritis,
Takayasu arteritis or systemic lupus erythematous, are rar-
er risk factors for aortic dissection, but 1 to 5% of patients
with aortitis develop aortic dissection [27, 28].
The role of atherosclerosis in the development of aortic
dissection remains unclear. Atherosclerosis is more com-
mon in patients with type B dissection than in those with
type A dissection [29]. In general, the prevalence and ex-
tent of atherosclerosis increases with age in both general
population and in patients with aortic dissection [23].
There is no association of diabetes mellitus or obesity with
aortic dissection or aneurysm [2].
Genetic diseases and conditions predisposing
to aortic dissection
Marfan syndrome and other inherited connective tissue
diseases, such as vascular-type Ehlers-Danlos syndrome or
Loeys-Dietz syndrome, are associated with aortic dissec-
tion especially in young patients [30]. Classic Marfan syn-
drome is caused by fibrillin 1 (FBN1) deficiency. Stud-
ies in animal models of Marfan syndrome suggest that
FBN1 mutations cause morphological changes in vascular
smooth muscle cells and the release of matrix-degrading
enzymes leading to elastolysis, fibre calcification, and in-
flammation. The progression of these pathological changes
culminates in aneurysm formation and, eventually, aortic
dissection [31, 32]. The prevalence of type A dissection
among patients with Marfan syndrome at 60 years of age is
approximately 50% [33]. The vascular-type Ehlers-Danlos
syndrome is associated with defects in the synthesis of type
III procollagen, which is an important regulatory element
in type I collagen fibrillogenesis. The abnormal collagen
type I fibrillogenesis and abnormal vascular smooth mus-
cle cell signalling results in thinner intima media thickness
with higher wall stress and increased risk of arterial dissec-
tion and rupture [34].
Mutations in genes encoding transforming growth factor β
receptors 1 and 2 are responsible for Loeys-Dietz and Mar-
fan-like syndrome. Affected patients have a high risk of
aortic dissection or rupture at an early age and with aortic
diameters that normally would not be predictive for these
events [35].
Congenital bicuspid aortic valve is the most common car-
diovascular malformation, occurring in 1 to 2% of the gen-
eral population, and is a risk factor for aortic aneurysm and
dissection [36]. Aortic disease and a bicuspid aortic valve
are connected with each other by mechanisms similar to
those described for Marfan syndrome, namely vascular
matrix remodelling due to the deficient elastic fibre com-
ponents, such as elastin, fibrillin or emilin, and increased
matrix metalloproteinase release [37, 38]. Mutations in the
following genes, among others, have been associated with
bicuspid aortic valve and aortic complications: NOTCH1
(isolated and familial bicuspid aortic valve and left ven-
tricular outflow tract defects), ACTA2 and TGF-β2 (bicus-
pid aortic with familial aortic aneurysm), and FNB1 (iso-
lated bicuspid aortic valve and bicuspid aortic valve with
Marfan syndrome). Moreover, family-based linkage analy-
ses have revealed associations of the genomic regions on
chromosomes 18q, 5q and 13q with bicuspid aortic valve
and cardiac malformations, but no genes harbouring under-
lying mutations have been identified. Except for NOTCH1,
the genetic associations with bicuspid aortic valve may be
the result of confounding with coexisting diseases [39].
Nonetheless, the prevalence of aortic dilatation and
aneurysm increases with age in patients with a bicuspid
aortic valve, and the risk of acute aortic complications,
such as dissection and rupture, is eight times higher in af-
fected patients than in the general population [40, 41].
Moreover, recent genome-wide association studies showed
that genetic variants in FNB1, LRP1, and ULK4 genes pre-
dispose individuals to non-familial thoracic aortic dissec-
tion [42].
Diagnosis by clinical assessment and imaging
Since aortic dissection is a dynamic process that may occur
in any segment of the aorta, the spectrum of the clinical
presentation is broad. Severe chest or back pain, described
as sharp or stabbing, with abrupt onset is the most common
presenting symptom of the acute aortic dissection. In less
than half of the patients presenting with acute type A dis-
section, pulse deficit, murmur of aortic regurgitation, hy-
potension, syncope or other neurological findings are re-
ported. Abdominal pain and hypertension are more fre-
quent in the patients with type B dissection than in those
with type A dissection [4]. Symptoms may mimic more
common conditions, such as myocardial infarction or pul-
monary embolism. However, typical physical findings can
even be absent. Therefore, aortic dissection is often diffi-
cult to diagnose, and a high clinical index of suspicion is
required. Nonetheless, the early and accurate diagnosis is
essential for choosing the appropriate surgical or medical
interventions to reduce the high lethality, which is around
1% per hour after symptom onset in untreated patients
[43].
Both chest X-ray and 12-lead electrocardiogram (ECG)
may be helpful in the evaluation of suspected aortic dissec-
tion, but a substantial number of patients do not show any
abnormalities in these examinations (12 and 31%, respec-
tively). In about 50% of patients, a widened mediastinum
or abnormal aortic contour is present in the chest X-ray.
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The most common ECG finding is the presence of nonspe-
cific ST-segment or T-wave changes. Rarely, ECG changes
typical for myocardial infarction, such as ST-segment ele-
vation or new Q waves, can be found in patients with acute
type A aortic dissection [4]. According to the Internation-
al Registry of Acute Aortic Dissection (IRAD) study, ECG
alterations suggestive of myocardial ischaemia are likely to
delay the correct diagnosis of aortic dissection [44]. Taken
together, sensitivity and specificity of both chest X-ray and
ECG are too low for the rule-out and rule-in of aortic dis-
section.
Transthoracic echocardiography (TTE) offers rapid and
noninvasive assessment of several aortic segments, partic-
ularly the aortic root and proximal ascending aorta. How-
ever, it suffers from limited diagnostic sensitivity, so that
negative findings on TTE do not allow any reliable ex-
clusion of aortic dissection. It is also limited in patients
with an abnormal chest wall configuration, obesity or pul-
monary emphysema, and in those on mechanical ventila-
tion. Nonetheless, owing to its broad availability, rapidi-
ty, and additional information on cardiac and aortic status,
TTE has been recommended as the initial imaging modali-
ty when aortic dissection is clinically suspected [5, 45].
A systematic review on the diagnostic accuracy of tran-
soesophageal echocardiography (TOE), contrast-enhanced
computed tomography (CT), and magnetic resonance
imaging (MRI) for suspected thoracic aortic dissection re-
ports pooled sensitivity of 98 to 100% and specificity of 95
to 98% for all three imaging techniques [46].
The portable TOE is advantageous in emergency situations
with time constraints and in patients with haemodynamic
instability, and overcomes the limitations of the TTE.
However, the quality of TOE examination depends on the
observer and their experience. False positive or false nega-
tive findings can arise easily when interpreted by unskilled
individuals or a single person [47]. It also suffers from the
poor spatial resolution and blind spots caused by interven-
ing anatomical structures (fig. 2).
MRI is considered the most accurate diagnostic technique
in the assessment of aortic dissection, but is rarely used as
the initial imaging technique due to the lack of availability,
time delay, incompatibility with implanted metal devices,
or difficulties to monitor the patient during the examina-
tion. MRI is highly suitable for serial follow-up studies in
patients with known aortic disease [5].
Contrast-enhanced CT is probably the most widely used
imaging technique in the diagnosis of aortic dissection. It
Figure 2: Transoesophageal echocardiographic image of the inti-
mal flap in type A dissection.
provides fast image acquisition and processing with the
ability to obtain complete 3D datasets of the entire aorta.
However, CT exposes patients to ionising radiation and to
contrast agents that may cause allergic reactions or renal
failure [5, 46]. According to the IRAD study, prompt chest
CT scan as the initial test is associated with the quickest
diagnostic time [44]. Moreover, the important findings of
imaging, such as extent of the dissection and regurgitation,
size of the false and true lumen, involvement of the arterial
branches, or presence of hematoma, can support the man-
agement (fig. 3).
Circulating biomarkers
As yet, blood tests play only a minor role in the assessment
of patients with suspected aortic dissection. D-dimers are
commonly used in the diagnosis of pulmonary embolism,
but they can also support diagnosis of aortic dissection.
The cut-off level of 500 ng/ml widely used for ruling out
pulmonary embolism can also be applied for ruling out
aortic dissection within the first 24 hours after onset of
symptoms [48]. A meta-analysis of the diagnostic perfor-
mance of D-dimers in aortic dissection shows very high
sensitivity of 97% and a rather poor specificity of 56%.
However, an excellent negative likelihood ratio of 0.06 al-
lows reliable ruling out of aortic dissection in low-risk pa-
tients who are unlikely to benefit from aortic imaging [49,
50].
About 50% of patients with aortic dissection have positive
high sensitive troponin T. Similarly to an ECG suggestive
of myocardial ischaemia, positive troponin T test results
were found to delay the diagnosis of aortic dissection. The
concomitant presence of elevated troponin and ECG ab-
normalities typical for myocardial infarction increases the
risk of misdiagnosis and, hence, the probability of inappro-
priate management, such as coronary angiography or in-
tense antithrombotic treatment [51]. Elevated cardiac tro-
ponins at the time of hospital admission for suspected
acute aortic dissection are associated with an increased risk
of in-hospital mortality [52].
Several inflammatory markers, like IL-6, IL-8, IL-10 or tu-
mour necrosis factor-alpha (TNF-α), have been proposed
as potentially useful in the diagnosis of the aortic dis-
section [53]. Although inflammation is one of the major
processes involved in the development of the aortic dis-
section, the specificity of these biomarkers may prove too
low for successful implementation as diagnostic markers in
Figure 3: Computed tomography scan of type A dissection with
haematoma.
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aortic dissection. Other major targets for biomarker seek-
ing are components of the extracellular matrix. For ex-
ample, circulating elastin degradation products (sELAF)
are elevated in patients with aortic dissection, but they
also increase with age in healthy subjects. Another lim-
itation of sELAF is its almost negligible increase in pa-
tients with a thrombosed false lumen [54]. Both MMP-8
and MMP-12 reflect the active aortic wall remodelling in
aortic dissection and appear to be more specific and sen-
sitive biomarker candidates [55, 56]. However, more stud-
ies are needed to confirm these intriguing data. The smooth
muscle myosin heavy chain, which is released after my-
ocytic death, shows satisfactory diagnostic performance,
but its rapid decrease already several hours after the onset
of symptoms limits it application to the patients with early
presentation [57]. Calponin, the smooth muscle analogue
of troponin, has relatively low specificity and sensitivity
and therefore cannot be used in clinical practice as a single
biomarker [58].
European guidelines for the diagnosis and
monitoring of patients with aortic diseases
The European Society of Cardiology (ESC) recommends
estimating a priori risk of aortic dissection by assessing
predisposing conditions (e.g., connective tissue diseases,
known aortic aneurysm or aortic valve disease), pain fea-
tures (abrupt onset and severe intensity), and by clinical
examination (pulse deficit, systolic blood pressure differ-
ence, aortic diastolic murmur, hypotension or shock). The
pre-test probability reached thereby is especially important
in haemodynamically stable patients, where the diagnostic
work-up is highly dependent on the risk status. In patients
with low risk of aortic dissection, measurement of D-
Dimer, TTE and chest X-ray should be chosen for the ini-
tial diagnostic examination. In patients with high probabil-
ity of aortic dissection and inconclusive TTE results, TOE
or contrast-enhanced CT are recommended as the diagnos-
tic imaging modalities [5] (table 2).
Patients with known aortic aneurysm, genetic connective
tissue disorders or a bicuspid aortic valve should undergo
serial assessment of the aorta until it reaches a critical di-
ameter at which the risk of dissection or rupture signif-
icantly increases. Elective surgery in patients with Mar-
fan syndrome and bicuspid aortic valve is indicated when
the aortic diameter exceeds 50 mm and 55 mm, respec-
tively. Lower thresholds are to be considered if additional
risks factors are present, such as a family history of dis-
section, size increase <3 mm/year or severe aortic regur-
gitation. The most suitable method for serial examination
is MRI, which allows visualisation of the entire aorta and
does not expose patients to ionising radiation or contrast
agents. The monitoring of patients with newly diagnosed
bicuspid aortic valves can also be conducted with TTE.
However, when the aortic diameter reaches 45 mm or its
increase >3 mm/year, the progression of dilation should be
checked with the use of MRI or CT [5, 59].
Conclusion
Because of the extremely high lethality of 1 to 2% per hour
after symptom onset in untreated patients [43], aortic dis-
section should have an important place in the awareness
of physicians in the evaluation of emergency patients with
acute chest pain. Delays in the diagnosis and treatment of
aortic dissection are more frequently observed in non-ter-
Table 2: Comparison of diagnostic methods in aortic dissection.
Diagnostic method Advantages Disadvantages Recommendations
of ESC [5]
Class of recommenda-
tion*
Level of evi-
dence†
D-dimer measurement • Fast and easily accessible
• Very high sensitivity of
97%
• Poor specificity of 56% • Only patients with a priori
low risk of aortic dissection
IIa B
Chest X-ray • Fast and noninvasive • Low sensitivity and specificity • Only patients with a priori
low risk of aortic dissection
IIb C
Transthoracic echocardiog-
raphy
• Rapid and noninvasive • Restricted in patients with ab-
normal chest wall, obesity, pul-
monary emphysema and me-
chanical ventilation
• Not all aortic segments can be
visualised
• Initial imaging examination I C
• Unstable patients with suspi-
cion of aortic dissection
I CTransoesophageal echocar-
diography
• Overcomes limitations of
transthoracic echocardiogra-
phy
• Suitable for haemodynami-
cally instable patients
• excellent sensitivity of 95%
and specificity of 95%
• Semi-invasive and requires se-
dation and blood pressure con-
trol
• Not feasible in patients with
oesophageal diseases
• Tends to be observer and ex-
perience dependent
• Not all aortic segments can be
visualised
• Stable patients with suspi-
cion of aortic dissection
IIa C
• Unstable or stable patients
with suspicion of aortic dissec-
tion
I CContrast-enhanced comput-
ed tomography
• Fast image acquisition
• Possibility of 3D images of
entire aorta
• Excellent sensitivity of
100% and specificity of 98%
• Exposure to ionising radiation
and contrast agents
• As repetitive imaging in case
of initially negative finding and
persistence suspicion
I C
• Stable patients with suspi-
cion of aortic dissection
I CMagnetic resonance imag-
ing
• Excellent sensitivity of 98%
and specificity of 98%
• Visualisation of entire aorta
• Incompatible with implanted
metal devices and pacemakers
• Problematic patient’s monitor-
ing during examination
• Lack of widespread availability
in the emergency settings
• As repetitive imaging in case
of initially negative finding and
persistence suspicion
I C
* Class of recommendation: I - is recommended / is indicated; IIa - should be considered; IIb - may be considered † Level of evidence: B - data derived from a single randomised
clinical trial or large nonrandomised studies; C - consensus of opinion of the experts and/or small studies, retrospective studies, registries
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tiary hospitals with low exposure to the aortic emergen-
cies. Continuous medical education of primary care cen-
tres on the recognition of aortic dissection, introduction of
standardised protocols for the initial management of aortic
dissection, and improved communication with specialised
cardiovascular centres can halve the time from presenta-
tion to both confirmed diagnosis and surgical repair [60].
The reduction of deaths caused by aortic dissection also re-
quires improvement in preventive measures, both in diag-
nostics to identify and monitor individuals at increased risk
of aortic dissection and in preventive treatments. Imaging
technologies provide a robust foundation for diagnosing
and monitoring of aortic dilatation or dissection, but easi-
ly accessible and cost-effective blood tests play almost no
role. Novel validated blood biomarkers have the potential
to facilitate the clinical management of patients with either
suspected aortic dissection or individuals at increased risk
of aortic dissection or both.
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